Literature DB >> 11171087

Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice.

J M Armstrong1, J F Chen, M A Schwarzschild, S Apasov, P T Smith, C Caldwell, P Chen, H Figler, G Sullivan, S Fink, J Linden, M Sitkovsky.   

Abstract

Agonist binding to extracellular A2A adenosine receptors (A2ARs) inhibits the activation of virtually all tested functions of T-cells and can induce apoptosis in thymocytes. The evaluation of levels of expression of these immunosuppressive receptors is expected to clarify whether the absence of spare A2ARs (no 'receptor reserve') might be one of the mechanisms of attenuation of the effects of extracellular adenosine on T-cells. A2A transcript is found in T-cells and functional receptors can be demonstrated, but the density of receptor on T-cells is too low to be detected by radioligand binding. Studies of direct radioligand binding to murine brain with the selective A2AR agonist [3H]CGS21680 (2-(4-[(2-carboxyethyl)-phenyl]ethylamino)-5'-N-ethylcarboxamidoadenosine) established that striata levels of A2AR are virtually absent from A2A knock-out mice. Mice that are heterozygous (A2AR+/-) for the A2AR express significantly decreased levels of A2AR. To test for the presence of spare receptors in T-cells we took advantage of this gene dose effect and examined whether the decrease in the number of receptors in thymocytes from A2AR+/- mice was proportionately reflected in a decrease in the functional cAMP response of T-cells to adenosine. cAMP accumulation and apoptosis induced by adenosine and by A2AR agonist are of a lower magnitude in T-cells from A2AR+/- heterozygous mice than in T-cells from A2AR+/+ littermate control mice. These results indicate that there is no A2AR reserve in murine T-cells. Strongly decreased adenosine-triggered cAMP increases were detected in thymocytes from A2AR-/- mice, suggesting that A2B adenosine receptors cannot fully compensate for the loss of A2ARs in murine T-cells. We conclude that the number of A2ARs is the limiting factor in determining the maximal cAMP response of T-lymphocytes to extracellular adenosine, thereby minimizing the immunosuppressive effects of extracellular adenosine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171087      PMCID: PMC1221636          DOI: 10.1042/0264-6021:3540123

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Evidence for the lack of spare high-affinity insulin receptors in skeletal muscle.

Authors:  M Camps; A Gumà; F Viñals; X Testar; M Palacín; A Zorzano
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

2.  Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells.

Authors:  M Koshiba; H Kojima; S Huang; S Apasov; M V Sitkovsky
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

3.  Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system.

Authors:  D L Rosin; A Robeva; R L Woodard; P G Guyenet; J Linden
Journal:  J Comp Neurol       Date:  1998-11-16       Impact factor: 3.215

Review 4.  G protein-coupled receptors: functional and mechanistic insights through altered gene expression.

Authors:  D K Rohrer; B K Kobilka
Journal:  Physiol Rev       Date:  1998-01       Impact factor: 37.312

Review 5.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

6.  Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion.

Authors:  S Huang; S Apasov; M Koshiba; M Sitkovsky
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

7.  The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase.

Authors:  S G Apasov; M V Sitkovsky
Journal:  Int Immunol       Date:  1999-02       Impact factor: 4.823

8.  Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency.

Authors:  N Hashimoto; F Suzuki; I Tamai; H Nikaido; M Kuwajima; J Hayakawa; A Tsuji
Journal:  Biochem Pharmacol       Date:  1998-05-15       Impact factor: 5.858

9.  Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.

Authors:  R F Cox; E Meller; B L Waszczak
Journal:  Synapse       Date:  1993-08       Impact factor: 2.562

10.  Evidence against spare or uncoupled beta-adrenoceptors in the human heart.

Authors:  R H Schwinger; M Böhm; E Erdmann
Journal:  Am Heart J       Date:  1990-04       Impact factor: 4.749

View more
  38 in total

1.  Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.

Authors:  Zoltán H Németh; Balázs Csóka; Jeanette Wilmanski; Dazhong Xu; Qi Lu; Catherine Ledent; Edwin A Deitch; Pál Pacher; Zoltán Spolarics; György Haskó
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 2.  Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands.

Authors:  J F Kinsel; M V Sitkovsky
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood.

Authors:  Ning Yu; Xiaomei Li; Weiya Song; Dongmei Li; Daliang Yu; Xiaofeng Zeng; Mengtao Li; Xiaomei Leng; Xiangpei Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

Authors:  Paul E Zarek; Ching-Tai Huang; Eric R Lutz; Jeanne Kowalski; Maureen R Horton; Joel Linden; Charles G Drake; Jonathan D Powell
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

5.  Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

Authors:  Balázs Csóka; Leonóra Himer; Zsolt Selmeczy; E Sylvester Vizi; Pál Pacher; Catherine Ledent; Edwin A Deitch; Zoltán Spolarics; Zoltán H Németh; György Haskó
Journal:  FASEB J       Date:  2008-07-14       Impact factor: 5.191

Review 6.  Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists.

Authors:  Michail V Sitkovsky; Stephen Hatfield; Robert Abbott; Bryan Belikoff; Dmitriy Lukashev; Akio Ohta
Journal:  Cancer Immunol Res       Date:  2014-07       Impact factor: 11.151

7.  Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Authors:  Stephen M Hatfield; Jorgen Kjaergaard; Dmitriy Lukashev; Bryan Belikoff; Taylor H Schreiber; Shalini Sethumadhavan; Robert Abbott; Phaethon Philbrook; Molly Thayer; Dai Shujia; Scott Rodig; Jeffrey L Kutok; Jin Ren; Akio Ohta; Eckhard R Podack; Barry Karger; Edwin K Jackson; Michail Sitkovsky
Journal:  J Mol Med (Berl)       Date:  2014-08-15       Impact factor: 4.599

8.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

Review 9.  Adenosinergic signaling as a target for natural killer cell immunotherapy.

Authors:  Jiao Wang; Sandro Matosevic
Journal:  J Mol Med (Berl)       Date:  2018-08-01       Impact factor: 4.599

Review 10.  A2A receptors in inflammation and injury: lessons learned from transgenic animals.

Authors:  György Haskó; Pál Pacher
Journal:  J Leukoc Biol       Date:  2007-12-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.